Tenofovir disoproxil aspartate

Product Name: Tenofovir disoproxil aspartate
CAS NO.: 201341-05-1
Molecular formula:C19H30N5O10P
EINECS:606-442-6
Synonyms:TenofivirDisoproxilFumarate
Purity : 98% HPLC
Certificate:COA; HPLC; MSDS; TDS,etc.
MOQ : 100g
Shipping: DHL/FedEx/UPS/USPS Safe and fast delivery
Lead Time: 1-3 days
Warehouse: USA and Germany warehouse

Product Description

Xi'an Faithful BioTech Co., Ltd: Your Trusted Tenofovir disoproxil aspartate Powder Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd is mainly engaged in API and intermediate supply, and Tenofovir disoproxil aspartate is our featured product. We are committed to providing high-purity and highly stable raw materials for overseas customers. We become an intermediate bridge connecting upstream high-quality production capacity with downstream formulation production through efficient and reliable supply services.

Tenofovir disoproxil aspartate Introduction

Tenofovir disoproxil aspartate is a white or off white crystalline powder that belongs to the nucleotide reverse transcriptase inhibitor class. As a precursor drug of Tenofovir, it can quickly hydrolyze and release the parent drug after oral administration, effectively inhibiting HIV and HBV viruses. It has been listed as the first-line core drug of antiviral treatment for chronic hepatitis B and AIDS by many domestic and foreign guidelines, and has high clinical application and scientific research value.

Specifications

Item	Specification	Result
Appearance	White powder	white powder
Identification	retention time of the HPLC main peak should be consistent concordant with reference substance	Complies
Related Substances	Maximum single impurity≤0.5%	0.08%
Related Substances	Total impurities≤1.0%	0.27%
Water	≤1.0%	0.4%
Residue on Ignition	≤ 0.1%	Conforms
Heavy Metals	≤20ppm	Conforms
Purity	≥99.0%	99.6%
Conclusion	Complies with In-house standard

Application area of Tenofovir disoproxil aspartate

Used in combination with other antiviral drugs to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents.
It is a first-line recommended medication for patients with newly diagnosed chronic hepatitis B (HBV), which can effectively reduce the incidence of cirrhosis and liver cancer.
For complex patients infected with both HIV and HBV, Tenofovir disoproxil aspartate has dual antiviral activity.

Main Advantages

Concentrated raw material production capacity and mature technology

China is the core supplier of Tenofovir disoproxil aspartate raw materials worldwide, with mature production technology, large production capacity, and stable supply chain, which can effectively guarantee the demand for raw material use.

Good antiviral effect

Its antiviral effect is better than that of Adefovir dipivoxil, realizing rapid and powerful antiviral effect.

Long term effectiveness

Compared with similar drugs, Tenofovir disoproxil has a higher resistance gene barrier and is effective for long-term use.

Wide indication coverage and mature application

Approved for the treatment of both HIV and HBV infections, effectively addressing co infections and some drug resistance situations. The clinical treatment plan covers a wide range and the market application is extremely mature.

Why choose us

Integrate upstream supply chain, select high-quality raw materials, ensure product purity of over 98% and low impurities.
Professional service, from early consultation to order tracking, team members are available 24 hours a day to respond promptly to inquiries and messages.
Transportation safety, accumulated stable and safe transportation channels, product packaging is tight, and can be safely and quickly delivered.